New Market Study Published: Metastatic Brain Tumor - Pipeline Review, H2 2012
Global Markets Direct's, 'Metastatic Brain Tumor - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Metastatic Brain Tumor, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Metastatic Brain Tumor. Metastatic Brain Tumor - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites,...
View full press release